menu icon
Oncology for the Pharmaceutical Industry PGDip

Oncology for the Pharmaceutical Industry PGDip

Key information
DATA SOURCE : IDP Connect

Qualification type

Postgraduate Diploma

Subject areas

Oncology Pharmacy

Course type

Taught

Course Summary

This course covers all aspects of delivering care to patients, including treatment modalities, biological, psychosocial and ethical perspectives. Developed and delivered with well-established cancer institutes and oncological and palliative care expertise, you will experience a comprehensive and intellectually stimulating experience wherever you are in the world. The Oncology for the Pharmaceutical Industry course is designed specifically for professionals working in the pharmaceutical industry or those working in the health and palliative care profession. The course offers an insight into the evolution of drugs used for the treatment of cancer and related illnesses. You will focus on drug research and cutting down costs to find effective medicines to treat cancer.

You will develop detailed knowledge about the interrelationship between oncology and clinical cancer service provision. The course is suitable for those who wish to pursue a career in oncology pharmaceuticals, with a thorough understanding of oncology. Through the course you will develop clinical leadership, clinical excellence and the ability to cultivate interdisciplinary collaboration in the delivery of evidence based oncology. This includes sharing mutually valuable information to help develop clinical practice. You will be introduced to the basis of research in oncology, preparing you for further research within the field. The course is taught online, so you can choose to study anytime and anywhere. This flexibility means that you can fit your studies around your other commitments, plus learning online will develop your online literacy as a transferable skill.

Different course options

Study mode

Online

Duration

4 years

Start date

JAN-20

Modules

This module looks at how new cancer medicines are developed, marketed and introduced into clinical practice. The module includes practical examination of how healthcare providers assess the value and affordability of new cancer medicines. The wider context of the impact new concepts in personalised health care and new medicine technologies will be evaluated. This module will be studied in Semester 2.

Tuition fees

UK fees
Course fees for UK / EU students

For this course (overall cost)

£5,200

Average for all Postgrad courses (per year)

£5,202

International fees
Course fees for non-UK / EU students

For this course (overall cost)

£5,200

Average for all Postgrad courses (per year)

£12,227

Entry requirements

Students should have a 2:2 honours degree, or international equivalent, in a relevant discipline and working in the healthcare profession or related field. We will consider applications on an individual basis if you have lower or non-standard qualifications and are working in the healthcare profession or related field. You will also need to nominate a work place mentor to provide professional and specialist advice and guidance to support your progress through the course. View detailed entry requirements. You must be IT literate to complete these highly interactive courses online and have access to a computer with a printer and a reliable internet connection.

University information

Newcastle University is a world-leading university, advancing knowledge, providing creative solutions and solving global problems. The university is a founding member of the prestigious Russell Group, one of 24 leading research-intensive UK universities. In recent years, Newcastle University has developed a presence in three similarly vibrant and globally-connected locations – London, Singapore and Malaysia. These provide both a global...more

Similar courses at this uni

Cancer MD

Full time | 24 months | APR

Cancer PhD

Full time | 36 months | APR

Cancer MPhil

Full time | 12 months | APR

Cancer MRes

Full time | 12 months | SEP